For investors and entrepreneurs looking to build a company from the very beginning, the below is a list of CSU innovations that we have identified as having the potential to serve as a platform technology on which to base a company. Of course, we have new opportunities arising all of the time, so contact us to hear more about the latest innovations and entrepreneurial ventures happening at CSU.
Applicable to a wide variety of filters and applications, this platform technology appends short polymer chains to existing membrane filters. Under an applied magnetic field, the polymer chains induce localized stirring at the membrane surface and prevent fouling of the filter. No modification of the feedstock is required. Applicable to water-based and non-water-based solutions. Relevant to waste water treatment, desalination, dairy, and chemical synthesis.
Falling in the category of waste-to-energy innovation, this technology converts a portion of solid animal waste (i.e. manure) to methane, simultaneously addressing the dual problems of energy use and disposal of animal waste that are particularly prevalent at large animal feeding operations (CAFOs).
A suite of innovations pertaining to the use of highly controlled plasma to controllably remove tissue. Applications include the removal of biofilms (such as for tooth whitening) and the removal of hard tissue such as bone and tooth.
This technology allows simultaneous analysis of tens to hundreds of biological pairs (DNA, antibodies, proteins, etc) on a small microchip platform. Featured on the cover of lab-on-a-chip magazine, this technology has the potential to realize personalized medicine in a convenient, electronic readout format (as opposed to cumbersome fluorescent arrays). Also able to detect hydrocarbons in water, this technology may have application in environmental sensing (e.g., fracking, groundwater).
A method to treat chronic kidney disease in cats and other species, including dogs and humans, using in vitro-cultured, adipose tissue-derived mesenchymal stem cells (MSCs) from fully allogenic donors. This method would be the first treatment of its kind in humans and highly advantageous as the allogenic donor cells are easy to collect and expand.
A rearticulated bone model that is held together via industrial magnets. Easy to dismantle the model and reassemble, it is designed for instructive and/or educational purposes.
A device for volumetric imaging of animal extremities that uses cone beam computed tomographic techniques in an open configuration. The device consists of a radiation detector and a radiation source that move synchronously but oppositely in a circular path about the extremity of interest without interfering with the contralateral limb.
Having application to both cancer and infectious disease, this invention encompasses the use of liposomal bisphosphonates (LB) or other specific macrophage depleting agents to boost the effectiveness of many different types of conventional vaccines (recombinant, live vectored, killed organism or cell).
This is a method for administering a therapeutic agent to a subject via an electro-sprayed, phospholipid coating on an implantable medical device. The phospholipids may be modified to carry and deliver a variety of therapeutic agents.
A convenient and non-intrusive system designed to help owners avoid heat-induced stress on an animal. By monitoring skin temperature and humidity (heat index) and correlating to internal temperature, the device monitors the physiological condition of an animal and alerts owners to take preventative action when necessary.
A faster, less expensive, and more accurate diagnostic system based on microfluidics for the analysis of cell morphology, composition, and phenotyping with application for any condition that requires biopsy sampling, including cancer, infectious disease, and inflammation. Miniaturized and multiplexed, this system saves time while conserving sample and reagents, thereby reducing healthcare costs and providing better patient outcomes.